SCHEMBL5872948

SCHEMBL5872948

CCc1cccc2c(-c3nc(C(=O)N4CCN(C)CC4)c(-c4cccnc4)s3)n[nH]c12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.39
HTT P42858 1/20 0.39
DRD2 P14416 1/20 0.37
DRD3 P35462 1/20 0.37
ABCB1 P08183 1/20 0.36
ABCC1 P33527 1/20 0.36
ABCG2 Q9UNQ0 1/20 0.36
KDR P35968 1/20 0.36
PIM1 P11309 3/20 0.36
DYRK1A Q13627 3/20 0.36
ADORA2A P29274 2/20 0.35
ADORA2B P29275 2/20 0.35
HTR2C P28335 1/20 0.35
NAMPT P43490 1/20 0.35
CLK2 P49760 1/20 0.35
CLK3 P49761 1/20 0.35
KMT2A Q03164 1/20 0.35
PTGS2 P35354 1/20 0.35
PARP1 P09874 1/20 0.35
WNT1 P04628 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5795447 0.91 PIM1 (0.41) ALDH1A1HTTDRD2DRD3ABCB1
SCHEMBL5873096 0.85 DYRK1A (0.38) PIM1DYRK1AWNT1
SCHEMBL5770403 0.85 PIM1 (0.42) ALDH1A1HTTKDRPIM1DYRK1A
SCHEMBL5872946 0.85 HRH4 (0.40) ALDH1A1HTTKDRPIM1DYRK1A
SCHEMBL5769525 0.84 PIM1 (0.41) ALDH1A1HTTKDRPIM1DYRK1A
SCHEMBL5872880 0.83 CYP2C9 (0.43) ALDH1A1HTTDRD2DRD3PIM1
SCHEMBL5873073 0.83 PIM1 (0.40) ALDH1A1HTTKDRPIM1DYRK1A
SCHEMBL5873004 0.82 PIM1 (0.42) ALDH1A1HTTDRD2DRD3ABCG2
SCHEMBL5872872 0.82 MKNK1 (0.45) HTTDRD2DRD3PIM1HTR2C
SCHEMBL5773190 0.82 HTR2C (0.45) ALDH1A1HTTPIM1HTR2CKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6984652-B2 Gyrase inhibitors WARNER-LAMBERT COMPANY LLC (US) 2006-01-10 US disclosed
US-20050250823-A1 Gyrase inhibitors YAGER KRAIG 2005-11-10 US disclosed
US-20050054697-A1 Gyrase inhibitors PFIZER INC. 2005-03-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050054697-A1 Gyrase inhibitors TOP1, TOP2A, TOP2B ALDH1A1 2272/4885HTT 4301/4885DRD2 4757/4885
US-20050250823-A1 Gyrase inhibitors TOP1, TOP2A, TOP2B ALDH1A1 2272/4885HTT 4301/4885DRD2 4757/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.